TITLE

Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder

AUTHOR(S)

Tadić, André; Wagner, Stefanie; Gorbulev, Stanislav; Dahmen, Norbert; Hiemke, Christoph; Braus, Dieter F.; Lieb, Klaus

PUB. DATE

January 2011

SOURCE

BMC Psychiatry;2011, Vol. 11 Issue 1, p16

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Background: In Major Depressive Disorder (MDD), treatment outcomes with currently available strategies are often disappointing. Therefore, it is sensible to develop new strategies to increase remission rates in acutely depressed patients. Many studies reported that true drug response can be observed within 14 days (early improvement) of antidepressant treatment. The identical time course of symptom amelioration after early improvement in patients treated with antidepressants of all classes or with placebo strongly suggests a common biological mechanism, which is not specific for a particular antidepressant medication. However, the biology underlying early improvement and final treatment response is not understood and there is no established biological marker as yet, which can predict treatment response for the individual patient before initiation or during the course of antidepressant treatment. Peripheral blood markers and executive functions are particularly promising candidates as markers for the onset of action and thus the prediction of final treatment outcome in MDD. Methods/Design: The present paper presents the rationales, objectives and methods of a multi-centre study applying close-meshed repetitive measurements of peripheral blood and neuropsychological parameters in patients with MDD and healthy controls during a study period of eight weeks for the identification of biomarkers for the onset of antidepressants' action in patients with MDD. Peripheral blood parameters and depression severity are assessed in weekly intervals from baseline to week 8, executive performance in bi-weekly intervals. Patients are participating in a randomized controlled multi-level clinical trial, healthy controls are matched according to mean age, sex and general intelligence. Discussion: This investigation will help to identify a biomarker or a set of biomarkers with decision-making quality in the treatment of MDD in order to increase the currently disappointing remission rates of antidepressant treatment. Trial Registration: ClinicalTrials.gov: NCT00974155

ACCESSION #

59162074

 

Related Articles

• Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.  // BMC Psychiatry;2011, Vol. 11 Issue 1, p101 

  The article presents a study conducted by Armin Szegedi and colleagues to examine the effects of asenapine on depressive symptoms in manic-depressive persons experiencing acute manic or mixed episodes. The study shows that asenapine efficacy is superior to placebo as early as day two in the...

• Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder.  // BMC Psychiatry;2011, Vol. 11 Issue 1, p164 

  The article presents a research which examines whether antidepressants (ADs) are effective for treating people suffering from sub-threshold depression (SD). It is reported that, the researchers used tools like questionnaire on psychotropic drug consumption, to conduct the research. According to...

• Disrupting the rhythm of depression: design and protocol of a randomized controlled trial on preventing relapse using brief cognitive therapy with or without antidepressants. Bockting, Claudi L. H.; Elgersma, Hermien J.; van Rijsbergen, Gerard D.; de Jonge, Peter; Ormel, Johan; Buskens, Erik; Stant, A. Dennis; de Jong, Peter J.; Peeters, Frenk P. M. L.; Huibers, Marcus J. H.; Arntz, Arnoud; Muris, Peter; Nolen, Willem A.; Schene, Aart H.; Hollon, Steven D. // BMC Psychiatry;2011, Vol. 11 Issue 1, p8 

  Background: Maintenance treatment with antidepressants is the leading strategy to prevent relapse and recurrence in patients with recurrent major depressive disorder (MDD) who have responded to acute treatment with antidepressants (AD). However, in clinical practice most patients (up to 70-80%)...

• All antidepressants are created equal. Elliott, William T. // OB/GYN Clinical Alert;Feb2012 Pharmacology, p1 

  The article offers information on a study published in the periodical "Annals of Internal Medicine" that found no significant differences among antidepressants regarding their effectiveness in the treatment of major depressive disorder (MDD).

• Commentary. Dunner, David L. // Evidence Based Mental Health;Feb2007, Vol. 10 Issue 1, p16 

  The article provides the author's comment regarding the result of a medical research that said that Mirtazapine and nortriplyline are still effective for the treatments of depression in Great Britain. He said the results of the study show low remission rates for the treatment of depression,...

• The Clinical Neuroscience of Post Stroke Depression. Haroon, Ebrahim; Kumar, Anand // Current Neuropharmacology;Oct2004, Vol. 2 Issue 4, p353 

  Post stroke depression or PSD is believed to occur in ten to forty percent of all patients who survive stroke. These mood disturbances overlap with primary major depressive disorder in terms of symptom profile, natural history and response to antidepressant medications. Cognitive changes,...

• Acute reversible inactivation of the bed nucleus of stria terminalis induces antidepressant-like effect in the rat forced swimming test. Crestani, Carlos C.; Alves, Fernando H. F.; Correa, Fernando M. A.; Guimarães, Francisco S.; Joca, Sâmia R. L. // Behavioral & Brain Functions;2010, Vol. 6, p30 

  Background: The bed nucleus of stria terminalis (BNST) is a limbic forebrain structure involved in hypothalamopituitary-adrenal axis regulation and stress adaptation. Inappropriate adaptation to stress is thought to compromise the organism's coping mechanisms, which have been implicated in the...

• Repetition of suicide attempts across episodes of severe depression Behavioural sensitisation found in suicide group but not in controls. Brådvik, Louise; Berglund, Mats // BMC Psychiatry;2011, Vol. 11 Issue 1, p1 

  Background: Those who die by suicide and suffer from depression are known to have made more suicide attempts during their life-span as compared to other people with depression. A behavioural sensitisation or kindling model has been proposed for suicidal behaviour, in accordance with a...

• Internet-based treatment for older adults with depression and co-morbid cardiovascular disease: protocol for a randomised, double-blind, placebo controlled trial. Cockayne, Nicole L.; Glozier, Nick; Naismith, Sharon L.; Christensen, Helen; Neal, Bruce; Hickie, Ian B. // BMC Psychiatry;2011, Vol. 11 Issue 1, p10 

  Background: Depression, cardiovascular disease (CVD) risk factors and cognitive impairment are important causes of disability and poor health outcomes. In combination they lead to an even worse prognosis. Internet or webbased interventions have been shown to deliver efficacious psychological...

Read the Article